JOHN MENDLEIN - 08 Jun 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for John Mendlein, Ph.D.
Issuer symbol
OMGAQ
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 16:10:33 UTC
Previous filing
06 Jun 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +18,118 $0.000000 18,118 08 Jun 2022 Common Stock 18,118 $3.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.